Skip to main content

Table 2 Thrombogenic risk

From: Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

 Total patients% of the total population12.5 × 106/kg50 × 106/kg200 × 106/kg
Complication related to anticoagulation436   
 Hemorrhage at catheter191
 Epistaxis21811
 Petechiae191
Procoagulant events19   
 Portal thrombi191
Prematurely stopped infusion cycles436   
 Catheter problems2182
 Transfusional reaction19 1
 High D-dimer levels19  1